Fed and Fasted Single-dose Assessment of Bioequivalence of Dapagliflozin and Metformin Extended-release Fixed-dose Combination Tablets Relative to Single-component Dapagliflozin and Metformin Extended-release Tablets in Healthy Subjects

二甲双胍 生物等效性 达帕格列嗪 医学 耐受性 药理学 交叉研究 药代动力学 加药 内科学 2型糖尿病 不利影响 内分泌学 糖尿病 安慰剂 胰岛素 病理 替代医学
作者
David W. Boulton,Ming Chang,Steven C. Griffen,Catia Kitaura,Susan Lubin,Allyson Pollack,Frank LaCreta
出处
期刊:Clinical Therapeutics [Elsevier BV]
卷期号:38 (1): 99-109 被引量:13
标识
DOI:10.1016/j.clinthera.2015.11.010
摘要

Abstract

Purpose

In patients with type 2 diabetes mellitus, fixed-dose combinations (FDCs) of antihyperglycemic medications may provide complementary efficacy while reducing tablet burden and improving compliance. The aim of this study was to assess the bioequivalence and tolerability of 2 FDCs of dapagliflozin and metformin extended-release (XR) versus their individual component (IC) tablets.

Methods

An open-label, balanced, randomized, 2-way crossover, 4-arm study was conducted in 129 healthy Brazilian subjects (aged 18–55 years). Two oral doses of the FDCs (5 mg dapagliflozin and 500 mg metformin XR, and 10 mg dapagliflozin and 1000 mg metformin XR) were evaluated in fed and fasted states.

Findings

Under fed and fasted conditions the 5 mg dapagliflozin and 500 mg metformin XR FDC showed bioequivalence to its ICs. The 10 mg dapagliflozin and 1000 mg metformin XR FDC was bioequivalent to its ICs in fed subjects. Although AUC for the 10 mg dapagliflozin and 1000 mg metformin XR FDC was bioequivalent in fasted subjects, the Cmax for metformin was not bioequivalent to its ICs in fasted subjects (upper 90% CI was 127.5%, and thus outside the 80%–125% bioequivalence interval). The small increase in the fasted state is not considered clinically meaningful due to the small magnitude of the difference (9.2%), the lack of metformin Cmax being associated with efficacy or tolerability concerns, and the fasted state not being the recommended state for dosing of metformin XR. The safety profile and tolerability of the FDCs were similar to those of their ICs and no deaths or serious adverse events were reported.

Implications

Both FDCs of dapagliflozin and metformin XR were bioequivalent to their ICs in fed and fasted subjects, except for the metformin Cmax from the 10 mg dapagliflozin and 1000 mg metformin XR FDC in fasted subjects. These data support the use of a dapagliflozin and metformin XR FDC in patients with type 2 diabetes mellitus.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
哈基咪完成签到,获得积分10
刚刚
17000416发布了新的文献求助10
1秒前
秋风的应助被匆匆采纳,获得10
1秒前
路宽宽发布了新的文献求助10
1秒前
领导范儿的应助被wish0913采纳,获得10
2秒前
ffxxffh发布了新的文献求助10
3秒前
4秒前
卡黄99完成签到,获得积分10
4秒前
4秒前
壮观的沂完成签到,获得积分20
4秒前
yuzu发布了新的文献求助10
4秒前
4秒前
motal发布了新的文献求助10
4秒前
高泡泡完成签到,获得积分20
5秒前
大橙子发布了新的文献求助10
6秒前
6秒前
melo完成签到,获得积分10
7秒前
7秒前
7秒前
orixero的应助被April采纳,获得10
8秒前
8秒前
cdercder的应助被infinite采纳,获得10
9秒前
小白发布了新的文献求助10
9秒前
9秒前
Chllerye发布了新的文献求助10
10秒前
LL发布了新的文献求助10
11秒前
Maestro_S的应助被周一采纳,获得10
12秒前
mmm发布了新的文献求助10
13秒前
13秒前
舒适鸣凤的应助被mashibeo采纳,获得10
13秒前
ww不迷糊完成签到 ,获得积分10
13秒前
小二郎的应助被wishpgsuccessful采纳,获得10
13秒前
zz发布了新的文献求助10
13秒前
李健的小迷弟的应助被你好采纳,获得10
13秒前
14秒前
Orange的应助被yuzu采纳,获得10
14秒前
14秒前
ouyang发布了新的文献求助10
14秒前
无限完成签到 ,获得积分10
15秒前
852的应助被顺利毕业采纳,获得10
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8194041
求助须知:如何正确求助?哪些是违规求助? 9579979
关于积分的说明 21868799
捐赠科研通 7793641
什么是DOI,文献DOI怎么找? 3437477
关于科研通互助平台的介绍 2560942
邀请新用户注册赠送积分活动 2484251